Shuttling protein nucleolin is a microglia receptor for amyloid beta peptide 1-42

Biological and Pharmaceutical Bulletin

Volumn 36, Issue 10, 2013, Pages 1587-1593

  Ozawa, Daisuke ^a   Nakamura, Takashi ^a   Koike, Masanori ^a   Hirano, Kazuya ^a   Miki, Yuichi ^a   Beppu, Masatoshi ^a  

^a TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

Author keywords

Alzheimer's disease; Amyloid ; Microglia; Nucleolin

Indexed keywords

AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; APTAMER; CELL RECEPTOR; NUCLEOLIN; PROTEIN ANTIBODY;

ANIMAL CELL; ARTICLE; CELL SURFACE; CONTROLLED STUDY; GENETIC TRANSFECTION; MICROGLIA; NONHUMAN; PHAGOCYTOSIS; PROTEIN ANALYSIS; PROTEIN CONTENT; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; RAT; SURFACE PLASMON RESONANCE;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; BRAIN; CELL LINE; HEK293 CELLS; HUMANS; MICE; MICROGLIA; MONONUCLEAR PHAGOCYTE SYSTEM; PHAGOCYTOSIS; PHOSPHOPROTEINS; RATS; RNA-BINDING PROTEINS;

EID: 84887052922     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.b13-00432     Document Type: Article

References (40)

1. Duyckaerts C, Delatour B, Potier MC. Classification and basic pathology of Alzheimer disease. Acta Neuropathol., 118, 5-36 (2009).
2. Kang J, Lemaire HG, Unterbeck A, Salbaum JM, Masters CL, Grzeschik KH, Multhaup G, Beyreuther K, Muller-Hill B. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature, 325, 733-736 (1987). (Pubitemid 17054046)
3. Miller DL, Papayannopoulos IA, Styles J, Bobin SA, Lin YY, Biemann K, Iqbal K. Peptide compositions of the cerebrovascular and senile plaque core amyloid deposits of Alzheimer's disease. Arch. Biochem. Biophys., 301, 41-52 (1993). (Pubitemid 23227174)
4. Roher AE, Lowenson JD, Clarke S, Wolkow C, Wang R, Cotter RJ, Reardon IM, Zurcher-Neely HA, Heinrikson RL, Ball MJ, Greenberg BD. Structural alterations in the peptide backbone of betaamyloid core protein may account for its deposition and stability in Alzheimer's disease. J. Biol. Chem., 268, 3072-3083 (1993). (Pubitemid 23070928)
5. Masters CL, Simms G, Weinman NA, Multhaup G, McDonald BL, Beyreuther K. Amyloid plaque core protein in Alzheimer's disease and Down syndrome. Proc. Natl. Acad. Sci. U.S.A., 82, 4245-4249 (1985). (Pubitemid 15053619)
6. Jarrett JT, Berger EP, Lansbury PT Jr. The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease. Biochemistry, 32, 4693-4697 (1993). (Pubitemid 23162022)
7. Jarrett JT, Lansbury PT Jr. Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie? Cell, 73, 1055-1058 (1993). (Pubitemid 23180480)
8. Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science, 297, 353-356 (2002). (Pubitemid 34790756)
9. Boche D, Nicoll JA. The role of the immune system in clearance of Aβ from the brain. Brain Pathol., 18, 267-278 (2008). (Pubitemid 351430403)
10. Iwata N, Higuchi M, Saido TC. Metabolism of amyloid-beta peptide and Alzheimer's disease. Pharmacol. Ther., 108, 129-148 (2005). (Pubitemid 41527082)
11. Verdier Y, Zarandi M, Penke B. Amyloid beta-peptide interactions with neuronal and glial cell plasma membrane: binding sites and implications for Alzheimer's disease. J. Pept. Sci., 10, 229-248 (2004). (Pubitemid 38594184)
12. Ginisty H, Sicard H, Roger B, Bouvet P. Structure and functions of nucleolin. J. Cell Sci., 112, 761-772 (1999). (Pubitemid 29179310)
13. Nigg EA. Nucleocytoplasmic transport: signals, mechanisms and regulation. Nature, 386, 779-787 (1997). (Pubitemid 27181245)
14. Hirano K, Miki Y, Hirai Y, Sato R, Itoh T, Hayashi A, Yamanaka M, Eda S, Beppu M. A multifunctional shuttling protein nucleolin is a macrophage receptor for apoptotic cells. J. Biol. Chem., 280, 39284-39293 (2005). (Pubitemid 41713883)
15. Miki Y, Itoh T, Hirano K, Eda S, Hayashi A, Yamanaka M, Beppu M. Clearance of oxidatively damaged cells by macrophages: recog nition of glycoprotein clusters by macrophage-surface nucleolin as early apoptotic cells. Biol. Pharm. Bull., 32, 564-572 (2009).
16. Oguri E, Miki Y, Hirano K, Yamanaka M, Beppu M. Clearance of CD43-capped cells by macrophages: capping alone leads to phagocytosis. Biol. Pharm. Bull., 35, 551-558 (2012).
17. Miki Y, Oguri E, Hirano K, Beppu M. Macrophage recognition of cells with elevated calcium is mediated by carbohydrate chains of CD43. Cell Struct. Funct., 38, 43-54 (2013).
18. Semenkovich CF, Ostlund RE Jr, Olson MO, Yang JW. A protein partially expressed on the surface of HepG2 cells that binds lipoproteins specifically is nucleolin. Biochemistry, 29, 9708-9713 (1990). (Pubitemid 20355221)
19. de Verdugo UR, Selinka HC, Huber M, Kramer B, Kellermann J, Hofschneider PH, Kandolf R. Characterization of a 100-kilodalton binding protein for the six serotypes of coxsackie B viruses. J. Virol., 69, 6751-6757 (1995).
20. Nisole S, Said EA, Mische C, Prevost MC, Krust B, Bouvet P, Bianco A, Briand JP, Hovanessian AG. The anti-HIV pentameric pseudopeptide HB-19 binds the C-terminal end of nucleolin and prevents anchorage of virus particles in the plasma membrane of target cells. J. Biol. Chem., 277, 20877-20886 (2002). (Pubitemid 34967396)
21. Bose S, Basu M, Banerjee AK. Role of nucleolin in human parainfluenza virus type 3 infection of human lung epithelial cells. J. Virol., 78, 8146-8158 (2004). (Pubitemid 38944299)
22. Sinclair JF, O'Brien AD. Cell surface-localized nucleolin is a eukaryotic receptor for the adhesin intimin-gamma of enterohemorrhagic Escherichia coli O157:H7. J. Biol. Chem., 277, 2876-2885 (2002). (Pubitemid 34953321)
23. Jordan G. At the heart of the nucleolus. Nature, 329, 489-490 (1987).
24. Ban T, Hoshino M, Takahashi S, Hamada D, Hasegawa K, Naiki H, Goto Y. Direct observation of Aβ amyloid fibril growth and inhibition. J. Mol. Biol., 344, 757-767 (2004). (Pubitemid 39469218)
25. LeVine H 3rd. Thioflavine T interaction with synthetic Alzheimer's disease beta-amyloid peptides: detection of amyloid aggregation in solution. Protein Sci., 2, 404-410 (1993).
26. Wiesehan K, Stohr J, Nagel-Steger L, van Groen T, Riesner D, Willbold D. Inhibition of cytotoxicity and amyloid fibril formation by a D-amino acid peptide that specifically binds to Alzheimer's disease amyloid peptide. Protein Eng. Des. Sel., 21, 241-246 (2008). (Pubitemid 351431052)
27. Van Regenmortel MH. Use of biosensors to characterize recombinant proteins. Dev. Biol. Stand., 83, 143-151 (1994).
28. Mongelard F, Bouvet P. AS-1411, a guanosine-rich oligonucleotide aptamer targeting nucleolin for the potential treatment of cancer, including acute myeloid leukemia. Curr. Opin. Mol. Ther., 12, 107-114 (2010).
29. Oddo S, Billings L, Kesslak JP, Cribbs DH, LaFerla FM. Aβ immunotherapy leads to clearance of early, but not late, hyperphosphorylated tau aggregates via the proteasome. Neuron, 43, 321-332 (2004). (Pubitemid 39061125)
30. Siemers E, Skinner M, Dean RA, Gonzales C, Satterwhite J, Farlow M, Ness D, May PC. Safety, tolerability, and changes in amyloid beta concentrations after administration of a gamma-secretase inhibitor in volunteers. Clin. Neuropharmacol., 28, 126-132 (2005). (Pubitemid 40923411)
31. Walsh DM, Townsend M, Podlisny MB, Shankar GM, Fadeeva JV, El Agnaf O, Hartley DM, Selkoe DJ. Certain inhibitors of synthetic amyloid beta-peptide (Aβ) fibrillogenesis block oligomerization of natural Aβ and thereby rescue long-term potentiation. J. Neurosci., 25, 2455-2462 (2005). (Pubitemid 40365155)
32. Martin A, De Vivo G, Gentile V. Possible role of the transglutaminases in the pathogenesis of Alzheimer's disease and other neurodegenerative diseases. Int. J. Alzheimers Dis., 2011, 1-8 (2011).
33. Christian S, Pilch J, Akerman ME, Porkka K, Laakkonen P, Ruoslahti E. Nucleolin expressed at the cell surface is a marker of endothelial cells in angiogenic blood vessels. J. Cell Biol., 163, 871-878 (2003). (Pubitemid 37517893)
34. Hou L, Shao H, Zhang Y, Li H, Menon NK, Neuhaus EB, Brewer JM, Byeon IJ, Ray DG, Vitek MP, Iwashita T, Makula RA, Przybyla AB, Zagorski MG. Solution NMR studies of the Aβ1-40 and Aβ1-42 peptides establish that the Met35 oxidation state affects the mechanism of amyloid formation. J. Am. Chem. Soc., 126, 1992-2005 (2004). (Pubitemid 38228879)
35. Miki Y, Tazawa T, Hirano K, Matsushima H, Kumamoto S, Hamasaki N, Yamaguchi T, Beppu M. Clearance of oxidized erythrocytes by macrophages: involvement of caspases in the generation of clearance signal at band 3 glycoprotein. Biochem. Biophys. Res. Commun., 363, 57-62 (2007). (Pubitemid 47430094)
36. Boddaert J, Kinugawa K, Lambert JC, Boukhtouche F, Zoll J, Merval R, Blanc-Brude O, Mann D, Berr C, Vilar J, Garabedian B, Journiac N, Charue D, Silvestre JS, Duyckaerts C, Amouyel P, Mariani J, Tedgui A, Mallat Z. Evidence of a role for lactadherin in Alzheimer's disease. Am. J. Pathol., 170, 921-929 (2007).
37. Duus K, Hansen PR, Houen G. Interaction of calreticulin with amyloid beta peptide 1-42. Protein Pept. Lett., 15, 103-107 (2008). (Pubitemid 351206482)
38. Floden AM, Combs CK. Beta-amyloid stimulates murine postnatal and adult microglia cultures in a unique manner. J. Neurosci., 26, 4644-4648 (2006). (Pubitemid 44315365)
39. Takata K, Kitamura Y, Yanagisawa D, Morikawa S, Morita M, Inubushi T, Tsuchiya D, Chishiro S, Saeki M, Taniguchi T, Shimohama S, Tooyama I. Microglial transplantation increases amyloidbeta clearance in Alzheimer's model rats. FEBS Lett., 581, 475-478 (2007). (Pubitemid 46149623)
40. Kitamura Y, Shibagaki K, Takata K, Tsuchiya D, Taniguchi T, Gebicke- Haerter PJ, Miki H, Takenawa T, Shimohama S. Involvement of Wiskott-Aldrich syndrome protein family verprolin-homologous protein (WAVE) and Rac1 in the phagocytosis of amyloid-beta(1-42) in rat microglia. J. Pharmacol. Sci., 92, 115-123 (2003). (Pubitemid 36833457)